References
1. Mahase E. Covid-19: one in three has neurological or psychiatric condition diagnosed after covid infection, study finds. BMJ 2021;373:n908.
2. Taquet M, Geddes JR, Husain M, et al. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry 2021;8:416–427.
4. Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020;77: 683–690.
5. Negrini F, Ferrario I, Mazziotti D, et al. Neuropsychological features of severe hospitalized coronavirus disease 2019 patients at clinical stability and clues for postacute rehabilitation. Arch Phys Med Rehabil 2021;102: 155–158.
6. Graham EL, Clark JR, Orban ZS, et al. (2021). Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 “long haulers”. Ann Clin Transl Neurol 2021;8:1073–1085.
7. Islam MF, Cotler J, Jason LA. Post-viral fatigue and COVID-19: lessons from past epidemics. Fatigue 2020;8:61–69.
8. Townsend L, Dyer AH, Jones K, et al. Persistent fatigue following SARSCoV-2 infection is common and independent of severity of initial infection. PLOS One 2020;15:e0240784.
9. Afari N, Buchwald D. Chronic fatigue syndrome: a review. Am J Psychiatry 2003;160:221–236.
10. Norrie J, Heitger M, Leathem J, et al. Mild traumatic brain injury and fatigue: a prospective longitudinal study. Brain Injury 2010;24:1528–1538.
11. Marshall M. The lasting misery of coronavirus long-haulers. Nature 2020; 585:339–341. .
12. Guan W, Ni Z, Hu Y, et al. (2020). Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708–1720.
13. Liotta EM, Batra A, Clark JR, et al. Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients. Ann Clin Transl Neurol 2020;7:2221–2230.
14. Bowles L, Platton S, Yartey N, et al. Lupus anticoagulant and abnormal coagulation tests in patients with Covid-19. N Engl J Med 2020;383: 288–290.
15. Harzallah I, Debliquis A, Drénou B. (2020). Lupus anticoagulant is frequent in patients with Covid-19. J Thromb Haemost 2020;18:2064–2065.
17. Hong I, Velozo CA, Li CY, et al. Assessment of the psychometrics of a PROMIS item bank: self-efficacy for managing daily activities. Qual Life Res 2016;25:2221.
18. Tay MRJ, Low YH, Lim CCT, et al. Covert subclinical neurocognitive sequelae during the rehabilitation course of severe coronavirus disease 2019. Am J Phys Med Rehabil 2021;100:39–43.
19. Iaccarino MA, Tenforde AS, Zafonte RD, et al. Neurological manifestation of COVID-19 and the enhanced role of physiatrists. Am J Phys Med Rehabil 2020;99:858–859.
20. Barker-Davies RM, O’Sullivan O, Senaratne KPP, et al. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med 2020;54:949–959.